Oramed Pharmaceuticals Statistics

Total Valuation

ORMP has a market cap or net worth of $103.60 million. The enterprise value is -$40.43 million.

Market Cap	103.60M
Enterprise Value	-40.43M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

ORMP has 40.63 million shares outstanding. The number of shares has increased by 3.80% in one year.

Shares Outstanding	40.63M
Shares Change (YoY)	+3.80%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	11.49%
Owned by Institutions (%)	13.15%
Float	36.94M

Valuation Ratios

The trailing PE ratio is 9.81.

PE Ratio	9.81
Forward PE	n/a
PS Ratio	153.71
Forward PS	58.04
PB Ratio	0.62
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.20.

Current Ratio	5.28
Quick Ratio	n/a
Debt / Equity	0.20
Debt / EBITDA	3.32
Debt / FCF	n/a
Interest Coverage	-11.13

Financial Efficiency

Return on equity (ROE) is 6.60% and return on invested capital (ROIC) is -6.79%.

Return on Equity (ROE)	6.60%
Return on Assets (ROA)	5.20%
Return on Capital (ROIC)	-6.79%
Revenue Per Employee	$51,846
Profits Per Employee	$804,308
Employee Count	13
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.19% in the last 52 weeks. The beta is 1.78, so ORMP's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	-23.19%
50-Day Moving Average	2.37
200-Day Moving Average	2.44
Relative Strength Index (RSI)	57.61
Average Volume (20 Days)	158,968

Short Selling Information

The latest short interest is 529,123, so 1.30% of the outstanding shares have been sold short.

Short Interest	529,123
Short Previous Month	467,789
Short % of Shares Out	1.30%
Short % of Float	1.43%
Short Ratio (days to cover)	2.59

Income Statement

In the last 12 months, ORMP had revenue of $674,000 and earned $10.46 million in profits. Earnings per share was $0.26.

Revenue	674,000
Gross Profit	674,000
Operating Income	-13.52M
Pretax Income	10.46M
Net Income	10.46M
EBITDA	9.81M
EBIT	9.59M
Earnings Per Share (EPS)	$0.26

Full Income Statement

Balance Sheet

The company has $176.59 million in cash and $32.56 million in debt, giving a net cash position of $144.03 million or $3.55 per share.

Cash & Cash Equivalents	176.59M
Total Debt	32.56M
Net Cash	144.03M
Net Cash Per Share	$3.55
Equity (Book Value)	166.64M
Book Value Per Share	4.10
Working Capital	143.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.22 million and capital expenditures -$57,000, giving a free cash flow of -$6.28 million.

Operating Cash Flow	-6.22M
Capital Expenditures	-57,000
Free Cash Flow	-6.28M
FCF Per Share	-$0.15

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,006.38% and 1,551.34%.

Gross Margin	100.00%
Operating Margin	-2,006.38%
Pretax Margin	1,551.34%
Profit Margin	1,551.34%
EBITDA Margin	1,455.34%
EBIT Margin	1,423.44%
FCF Margin	-931.60%

Dividends & Yields

ORMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.80%
Shareholder Yield	-3.80%
Earnings Yield	10.09%
FCF Yield	-6.06%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 1:12.

Last Split Date	Jan 23, 2013
Split Type	Reverse
Split Ratio	1:12

Scores

ORMP has an Altman Z-Score of 1.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.57
Piotroski F-Score	3